{"filings":[{"id":695574,"accession_number":"0001493152-26-025397","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-05-27T20:05:39+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Nexentis increases L.I.A. Pure Capital credit facility to EUR 10M, issues 1.85M share warrants at $1.00","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amended facility increases borrowing capacity from EUR 6M to EUR 10M, interest unchanged at 7% per annum.","Five-year warrant issued for 1,850,000 common shares at $1.00 per share; anti-dilution price maintenance added.","Repayment from project proceeds or 33% of future financing proceeds; outstanding after 5 years repaid within 30 days.","Company to file resale registration statement for warrant shares within 75 days, seek effectiveness within 90 days.","Drawdowns require Lender pre-approval; proceeds for operations and potential acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95475,"accession_number":"0001493152-26-020509","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Nexentis shareholders approve reverse stock split and discounted equity issuance at special meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split (1-for-2 to 1-for-500) approved with 2,855,535 for, 272,430 against.","Equity issuance proposal (up to 20% discount) approved: 2,230,497 for, 112,345 against (775,360 broker non-votes).","Facility amendment with L.I.A. Pure Capital Ltd. approved: 1,789,433 for, 98,561 against, 466,614 abstain.","Adjournment proposal approved with 2,949,940 for, 177,153 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95474,"accession_number":"0001493152-26-015246","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Nexentis Technologies to effect 1-for-7 reverse stock split effective April 7, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1-for-7 ratio; effective April 7, 2026 at 4:15 p.m. EDT.","Outstanding shares reduced from 5,111,362 to approx 730,309; fractional shares rounded up.","No change in authorized shares (495M common, 5M preferred) or par value; no dilution.","Post-split trading on Nasdaq begins April 8 under same symbol NXTS but new CUSIP number."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108583,"accession_number":"0001493152-26-010533","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Nexentis closes transfer of 98% stake in Save Foods to Voice Assist for 19.99% equity","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed on March 15, 2026; transferred all Save Foods shares owned (~98% of outstanding).","Consideration: 19.99% of Voice Assist common stock on fully-diluted basis post-closing.","Also entered Services Agreement with Voice Assist for advisory services with deferred cash/royalty consideration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108582,"accession_number":"0001493152-26-008175","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"N2OFF issues 600,000 common shares to consultants for IR and business development services","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 600,000 shares of common stock on February 20, 2026.","Shares were issued to consultants for investor relations and business development services.","Exempt from registration under Section 4(a)(2) of the Securities Act as a private transaction.","Shares are restricted and not registered for public resale."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108581,"accession_number":"0001493152-26-007988","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["5.03","7.01"],"status":"ready","headline":"N2OFF rebrands to Nexentis Technologies, shifts focus to AI-driven mitochondrial biotech","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change to Nexentis Technologies Inc. and ticker change to NXTS effective Feb 26, 2026.","Rebranding reflects integration of MitoCareX Bio with MITOLINE platform targeting mitochondrial SLC25 carriers.","Recent in vitro data showed anti-tumor activity and reduction in pro-inflammatory markers.","Company continues to manage RTB solar energy investments as non-core asset base."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108580,"accession_number":"0001493152-26-002031","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"N2OFF to transfer 98% stake in Save Foods to Voice Assist for 19.99% of Voice Assist stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["N2OFF to transfer 98% stake in Save Foods to Voice Assist; consideration: 60.2M Voice Assist shares (19.99% fully diluted).","Closing expected within 90 days, subject to due diligence, tax opinion, and consents.","Services Agreement: N2OFF gets up to $1M deferred cash from Voice Assist financings, plus royalties and 75% of Ecolab claim proceeds.","Services Agreement runs through 2026; N2OFF may extend until full consideration received."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108579,"accession_number":"0001493152-26-001247","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"N2OFF issues 35,000 shares for investor relations services","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 35,000 shares of common stock to a consultant on January 8, 2026.","Shares issued in reliance on Section 4(a)(2) exemption from registration.","Consideration was investor relations services provided to the company.","No other terms or valuation disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125028,"accession_number":"0001493152-25-027962","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["3.02","5.07"],"status":"ready","headline":"N2OFF issues 60,000 shares for consulting; shareholders reelect directors, approve share plan amendment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 60,000 common shares to consultants for investor relations services under Section 4(a)(2) exemption.","Ronen Rosenbloom and Israel Berenstein reelected as Class I directors (1,263,038 votes for).","Approved increase in shares available under 2022 Share Incentive Plan (1,252,667 for, 29,576 against).","Advisory vote on board grants under the plan approved (1,255,346 for).","Ratified Somekh Chaikin (member of KPMG) as independent auditor for FY2025 (1,700,600 for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125025,"accession_number":"0001493152-25-021907","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K/A","filed_at":"2025-11-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"N2OFF files MitoCareX audited financials; target had $886K net loss, going concern doubt in 2024","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["MitoCareX net loss for 2024 was $886K, accumulated deficit $1,760K; cash used in operations $797K.","Auditor notes substantial doubt about MitoCareX's ability to continue as a going concern.","MitoCareX had short-term loan of $250K from N2OFF at 3% due Dec 2024; second $250K loan in Mar 2025.","Unaudited pro forma combined financials filed for six months ended Jun 30, 2025 and year ended Dec 31, 2024.","Updated business description and risk factors filed to supplement prior disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125027,"accession_number":"0001493152-25-019064","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["2.01","3.02","8.01","9.01"],"status":"ready","headline":"N2OFF closes acquisition of MitoCareX, issuing stock and $700K cash for 100% of biotech","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 100% of MitoCareX, a drug discovery company targeting resistant cancers including pancreatic and non-small cell lung cancer.","Consideration: $700,000 cash to SciSparc and ~1.17M shares (40% of N2OFF fully diluted capital) to the Sellers.","Sellers entitled to 30% of N2OFF financing proceeds (capped at $1.6M) for 5 years and milestone issuances up to 25% additional stock.","Board overlap: N2OFF Chairman Amitay Weiss and Director Liat Sidi also serve on SciSparc's board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125026,"accession_number":"0001493152-25-017377","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"N2OFF regains Nasdaq minimum bid price compliance; delisting risk resolved","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq confirmation on Oct 6, 2025 that bid price was ≥$1.00 for 10 consecutive business days (Sep 22 – Oct 3, 2025).","Previously disclosed non-compliance on March 28, 2025; matter now closed.","Compliance with Nasdaq Listing Rule 5550(a)(2) re-established, avoiding potential delisting.","Company continues to operate cleantech solar and post-harvest treatment businesses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141720,"accession_number":"0001493152-25-014952","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-09-25T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"N2OFF shareholders approve acquisition of MitoCareX Bio; closing targeted by early Oct 2025","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Stockholders voted 11.7M for, 197K against to approve the MitoCareX acquisition; reverse split and warrant share proposals also passed.","N2OFF will acquire MitoCareX from SciSparc (SPRC) and others for $700K plus shares equal to 40% of fully diluted stock.","Sellers get 30% of financing proceeds (capped at $1.6M) for 5 years and milestone issuances up to 25% of common stock.","N2OFF commits an initial $1M cash investment to support MitoCareX operations for two years post-closing.","A 1-for-35 reverse stock split was already effected on Sept 22; the approved split range (1:2 to 1:150) allows further action within one year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141719,"accession_number":"0001493152-25-013998","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"N2OFF announces 1-for-35 reverse stock split effective Sept 22, 2025","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reverse stock split ratio 1-for-35, effective for Nasdaq on September 22, 2025.","Outstanding shares reduced from ~33M to ~953k; fractional shares rounded up.","Split authorized by shareholders in June 2024 to regain Nasdaq compliance.","Trading symbol remains NITO; new CUSIP 80512Q501."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141718,"accession_number":"0001493152-25-012904","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["1.01","3.03","5.03","9.01"],"status":"ready","headline":"N2OFF effects 1-for-35 reverse stock split; adds €600K loan for battery study","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1-for-35 ratio, effective September 3, 2025; CUSIP changes.","Addendum No. 2 provides €600,000 loan at 7% to optimize battery storage near Melz PV project.","N2OFF committed 75% of the €600K addendum; loans mature upon sale of partnership or 5 years.","Previous €2.08M loan to partnership in July 2024 included €1.56M from N2OFF."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141717,"accession_number":"0001493152-25-012130","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-08-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"N2OFF (NITO) provides $372K bridge loan to MitoCareX Bio pending acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Loan principal $372,000 from N2OFF to MitoCareX Bio Ltd., term 6 months, interest at Israel Tax Authority USD rate +3%.","Disbursement in three tranches: $200K at signing, $86K on Sep 15, 2025, $86K on Oct 15, 2025.","L.I.A. Pure Capital Ltd. guarantees full repayment of principal and interest.","If acquisition closes, outstanding loan amount deducted from first-year allocation to MitoCareX.","Loan supports MitoCareX's ongoing costs until acquisition stockholder approval and closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141716,"accession_number":"0001493152-25-011919","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["2.03","1.01","3.02","9.01"],"status":"ready","headline":"N2OFF draws $1.5M first tranche of $3M advance; issues 8% promissory note due 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Received $1.5M on August 12, 2025 from YA II PN as first part of $3M advance under amended Purchase Agreement.","Promissory Note bears 8% annual interest (18% upon default), matures August 12, 2026.","Monthly repayments due via cash or equity (SEPA Advance Notices); prepayment allowed with Payment Premium.","Note issued in unregistered transaction under Section 4(a)(2) of Securities Act.","Advance was originally disclosed May 12, 2025 and amended July 25, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141715,"accession_number":"0001493152-25-011426","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["3.02","1.01","9.01"],"status":"ready","headline":"N2OFF amends purchase agreement with YA II PN; issues 574,325 commitment shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amends May 12 Purchase Agreement with YA II PN; extends payment terms on $3M promissory notes.","Issues 574,325 additional commitment shares (or pre-funded warrants) to investor within 3 business days.","Revised notes carry 8% interest (18% on default); maturity 12 months from issuance per amendment.","Advances: up to $1.5M within 60 days after new SEPA registration filed; another $1.5M after effective.","Shares issued in unregistered transaction relying on Section 4(a)(2) exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141714,"accession_number":"0001493152-25-011380","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"N2OFF amends MitoCareX acquisition: extends closing deadline, updates share counts and consideration caps","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Outside Date extended by 90 days to 270 days from original agreement date (Feb 25, 2025).","Fully-diluted share count updated to 32,808,629 (from 27,734,248) to reflect issuances after execution.","Additional consideration for sellers capped at $1.6M total, allocated 52.73% SciSparc, 31.51% Alon, 15.76% Ciro.","Post-closing N2OFF shares outstanding projected at 56,939,836, up from current 30,096,412 (increase ~26.8M).","Milestone-based Additional Purchaser Stock of up to 25% of post-closing fully-diluted capital, vesting by Dec 31, 2028."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159622,"accession_number":"0001641172-25-012067","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"N2OFF extends acquisition deadline for MitoCareX by 90 days and provides additional $250K loan","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment to Securities Purchase and Exchange Agreement extends closing deadline by 90 days to 180 days from Feb 25, 2025.","Third loan agreement provides $250,000 to MitoCareX, maturing in 6 months, with interest at Israel Tax Authority rate +3%.","Amendments to two prior $250,000 loans each extend their maturity by 180 days.","New loan guaranteed by L.I.A. Pure Capital and will be deducted from future allocation if acquisition closes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159621,"accession_number":"0001641172-25-009993","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["2.03","1.01","3.02","9.01"],"status":"ready","headline":"N2OFF secures up to $3M debt facility via Purchase Agreement with YA II PN","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Up to $3M in two tranches: $1.5M after SEC filing, $1.5M after effectiveness.","Notes bear 8% interest, mature 12 months; $150k monthly principal+interest due starting day 61.","Company pays $15k structuring fee and issues 675,675 commitment shares (~$300K value at pre-deal close).","Default interest 18%; prepayment allowed with 5% premium; debt may be repaid via SEPA advances.","~$16M remains under existing SEPA, but new registration needed to draw further."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159620,"accession_number":"0001641172-25-009678","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["3.02","5.02"],"status":"ready","headline":"N2OFF issues 4.4M shares of common stock as compensation to CEO, CFO, and consultants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["600,000 shares issued to CEO David Palach; 300,000 to CFO Lital Barda under 2022 Share Incentive Plan.","3,200,000 shares issued to consultants outside the Plan for financial, IR and business development services.","300,000 shares issued to a consultant for accounting and controller services under the Plan.","All shares issued on May 12, 2025, exempt from registration under Section 4(a)(2)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159619,"accession_number":"0001641172-25-003600","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-04-10T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"N2OFF sells 100% stake in NTWO OFF Ltd. for 15,000 NIS (~$4,000)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 4,200,000 shares of NTWO (100% ownership) to Yaaran Investments for 15,000 NIS.","Prior stock exchange agreement from July 2023 is nullified; all obligations cancelled.","Directors David Palach and Udi Kalifi resigned from NTWO's board upon closing.","Company exits its investment in NTWO for nominal consideration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177993,"accession_number":"0001641172-25-001431","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"N2OFF receives Nasdaq bid price deficiency notice; 180-day cure period","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["On March 28, 2025, Nasdaq notified N2OFF that its stock closed below $1.00 for 30 consecutive business days.","Company has until September 24, 2025 to regain compliance with Nasdaq Listing Rule 5550(a)(2).","If not compliant, may seek a second 180-day period by meeting other listing standards and planning a reverse stock split.","Common stock continues trading on Nasdaq under symbol NITO during the compliance period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177992,"accession_number":"0001493152-25-010993","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"N2OFF amends beneficial ownership limit from 4.99% to 9.99% on December 2024 warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment raises beneficial ownership cap from 4.99% to 9.99% for warrants issued in December 2024 private placement.","All other terms of the Securities Purchase Agreement remain in full force and effect.","Amendment effective March 19, 2025; required holders consented."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177991,"accession_number":"0001493152-25-010502","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-03-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"N2OFF loans $250K to MitoCareX, pending acquisition funding","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$250,000 loan to MitoCareX Bio Ltd., 6-month term, interest at Israel tax rate + 3%.","Loan guaranteed by L.I.A. Pure Capital Ltd.","Second $250K loan to MitoCareX; prior loan dated Dec 22, 2024.","Loan intended to cover MitoCareX costs until closing of Feb 2025 acquisition agreement.","If acquisition closes, outstanding loan amount deducted from first-year allocation to MitoCareX."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177990,"accession_number":"0001493152-25-008629","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"N2OFF signs shareholders agreement to acquire 70% of SB Impact 4; to lend €2.3M for Sicily battery projects","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["N2OFF will purchase 70% of SBI4 shares from Solterra Brand Services Italy on final closing date.","N2OFF lending €2.3M at 7% annual interest for two 196 MW battery storage projects in Sicily.","Board: N2OFF appoints 2 directors, SB 1 if SB holds ≥20.01%; N2OFF gets all 3 if SB falls below 20%.","Profit on project sale split by price per MW: up to €30k – prorata; €30-60k – SB 40%; above €60k – SB 50%.","If N2OFF fails to fund drawdowns within 30 days, SB may repurchase shares at €10k company valuation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177989,"accession_number":"0001493152-25-008294","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-02-26T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"N2OFF signs definitive agreement to acquire MitoCareX Bio in stock-cash deal","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["N2OFF will pay $700,000 cash to SciSparc for 4,961 shares and issue common stock totaling 40% of fully diluted capital to all sellers.","Sellers eligible for milestone-based issuance of up to 25% additional common stock and 30% of N2OFF financing proceeds capped at $1.6M over 5 years.","N2OFF commits initial $1M investment in MitoCareX plus ongoing funding; MitoCareX becomes wholly-owned subsidiary upon closing.","Transaction subject to N2OFF stockholder approval; board members Amitay Weiss and Liat Sidi also serve on SciSparc board (related party)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177988,"accession_number":"0001493152-25-005327","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-02-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"N2OFF regains Nasdaq minimum bid price compliance; delisting risk removed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq notified N2OFF on Feb 6, 2025 of compliance with $1.00 minimum bid price for 10 consecutive business days (Jan 23 - Feb 5).","Company had received non-compliance notice in July 2024; extension granted to July 7, 2025 on Jan 7, 2025.","Matter is now closed; no further action required from Nasdaq.","Regaining compliance removes potential delisting from Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177987,"accession_number":"0001493152-25-002282","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-01-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"N2OFF subsidiary Save Foods wins European patent opposition (EP2615932) filed by Ecolab","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Save Foods Ltd. prevailed in opposition to its European patent EP2615932 filed by ECOLAB Inc.","Patent covers a method of protecting edible matter using a specific performic acid composition.","ECOLAB may appeal the decision to the European Patent Register by April 9, 2025.","CEO states the outcome strengthens Save Foods' position in negotiations with global companies.","Save Foods' technology reduces hazardous pesticide use by at least 50%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177986,"accession_number":"0001493152-25-001311","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-01-08T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"N2OFF granted additional 180 days by Nasdaq to meet minimum bid price rule through July 7, 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq gave second 180-day extension until July 7, 2025, to regain $1.00 minimum bid price compliance.","Company must show closing bid at least $1.00 for 10 consecutive trading days to cure.","If not cured by July 7, 2025, Nasdaq will delist the company; appeal possible.","Company may effect a reverse stock split if necessary to regain compliance.","No immediate impact on listing or trading under symbol NITO on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177985,"accession_number":"0001493152-25-000353","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2025-01-06T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"N2OFF closes $1.5M private placement; issues shares and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 1,704,116 common shares, pre-funded warrants for 4,545,884 shares, and warrants for 9,375,000 shares on Jan 2, 2025.","Gross proceeds of $1,500,000 from the private placement consummated under a Dec 10, 2024 purchase agreement.","Exemption from registration claimed under Section 4(a)(2) of the Securities Act.","Placement significantly increases total potential shares outstanding by up to 15,625,000 if warrants exercised."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194687,"accession_number":"0001493152-24-051967","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-12-26T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"N2OFF loans $250K to MitoCareX; issues 650K shares to directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Loaned $250,000 to MitoCareX Bio Ltd. at Israel Tax Authority rate + 3%, due in six months.","Loan guaranteed by L.I.A. Pure Capital Ltd. If MitoCareX becomes a subsidiary, outstanding amount deducted from future allocations.","Issued 650,000 common shares to directors under 2022 Share Incentive Plan on December 23, 2024.","Board and compensation committee recommended issuance; non-binding stockholder approval received November 13, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194686,"accession_number":"0001493152-24-049786","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-12-12T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"N2OFF corrects private placement terms; warrant amended with $0.048 floor price","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Corrects prior 8-K: each unit = 1 share (or 1 pre-funded warrant) + 1.5 warrants at $0.24/unit.","Units and underlying securities will not be issued until 15 days after Nasdaq listing submission.","Common warrant amended to include floor price of $0.048 (20% of $0.24) on anti-dilution adjustments.","Gross proceeds of ~$1.5M from the private placement previously disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194685,"accession_number":"0001493152-24-049464","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["1.01","2.01","3.02"],"status":"ready","headline":"N2OFF raises $1.5M in private placement; acquires 65% of Plantify via debt settlement","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Gross proceeds of ~$1.5M from 6.25M units at $0.24/unit; each unit includes common stock and warrants.","Plantify issued 2.42M shares to N2OFF at CDN$0.848/share to settle CDN$2.05M debt; N2OFF now owns 65% of Plantify.","Common warrants have 5-year term, exercise price $0.24; pre-funded warrants have $0.00001 exercise price, no expiration.","Pure Capital agreed not to exercise its facility warrant until stockholder approval; resale registration filing deadline extended."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194684,"accession_number":"0001493152-24-046456","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"N2OFF settles CDN$2.05M debt with Plantify, to hold 65.4% of its common shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Debt of CDN$2,052,879.39 settled via 2,420,848 Plantify shares at CDN$0.848 per share.","After closing, N2OFF will hold approximately 65.4% of Plantify's outstanding common shares.","Debt comprised CDN$1,691,342.47 from matured convertible debenture and US$258,240.66 from line of credit draws.","Closing conditional on TSX Venture Exchange approval; shares unregistered and subject to resale restrictions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194683,"accession_number":"0001493152-24-045115","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"N2OFF annual meeting: authorized capital increase fails; all other proposals pass","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Proposal to increase authorized shares from 500M to 10.005B failed; 2,886,707 for, 1,024,326 against (required majority of outstanding shares).","All other five proposals approved: director re-election of Arbib and Kalifi, 2022 Plan share increase, advisory share grant, auditor ratification, and equity issuance at up to 20% discount.","Annual meeting quorum was 41.16% of outstanding shares (3,923,277 of 9,530,515)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194682,"accession_number":"0001493152-24-044427","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"N2OFF amends bylaws to reduce stockholder quorum requirement from majority to 33.33%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New quorum threshold: holders of at least 33.33% of voting power present in person or by proxy.","Prior requirement was a majority of shares entitled to vote; change approved by board on Nov 11, 2024.","Amendment facilitates holding stockholder meetings with lower attendance threshold."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194681,"accession_number":"0001493152-24-039126","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-10-02T23:59:59+00:00","items":["2.03","1.01","3.02","7.01","9.01"],"status":"ready","headline":"N2OFF enters €6M credit facility, pursues spin-off and drug discovery acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["€6M non-recourse credit facility at 7% interest; warrant for 1.85M shares at $1.00 exercise price.","Board approved potential spin-off of cleantech units NTWO OFF and Save Foods into separate public company; N2OFF to retain ≥75% in Save Foods.","Non-binding LOI to acquire a computationally advanced drug discovery company at valuation of at least $5M (possible $2M increase).","Acquisition consideration would be cash and equity; company intends to tap new pharmaceutical market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210984,"accession_number":"0001493152-24-038118","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-09-25T23:59:59+00:00","items":["3.02","5.02"],"status":"ready","headline":"N2OFF issues 1.69M shares to officers, consultants and investor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 640,000 shares under 2022 Share Incentive Plan and 1,050,000 shares outside plan to consultants and officers on Sept 12, 2024.","CEO David Palach received 320,000 shares; CFO Lital Barda received 160,000 shares.","Issued 50,000 shares to an investor on Sept 23, 2024, under a standby equity purchase agreement dated Dec 23, 2023.","Shares were issued in reliance on Section 4(a)(2) exemption for transactions not involving public offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210983,"accession_number":"0001493152-24-035936","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-09-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"N2OFF and Solterra announce ~10% extra grid capacity for solar PV project; evaluating expansion or battery storage","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Grid connection approval in Meltz, Germany exceeds required 97 MW by ~10% for 111 MWp project.","Two options to capitalize: increase capacity up to 10% or add battery storage.","Company examining pathways to enhance profitability; potential higher project valuation even if not pursued.","N2OFF CEO expresses excitement and commitment to maximize opportunity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210982,"accession_number":"0001493152-24-034046","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-08-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"N2OFF JV secures grid connection approval for 111 MWp solar project in Germany","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Joint venture with Solterra obtains approval to connect first PV solar project to power grid in Melz, Germany.","Project expected total capacity of 111 MWp; timeline and milestones remain on track.","Approval demonstrates project meets safety standards; reduces regulatory and operational risks.","Solterra manages a portfolio of ~300 MW cumulative capacity across Italy, Poland, and Germany."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210981,"accession_number":"0001493152-24-029704","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.03","1.01","7.01","9.01"],"status":"ready","headline":"N2OFF commits up to €1.56M for 50% profit rights in 111 MW German solar project","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["N2OFF and private investors loan €2.08M (N2OFF share €1.56M) to Solterra for 111 MWp Melz solar project; 7% interest, 5-year maturity.","N2OFF will receive 50% of the lenders' 50% profit participation, effectively 25% of project net earnings.","First project in Melz, Germany received municipal approval and indicative grid connection solution from regional energy provider.","Agreement includes right of first refusal for additional project investments up to €6 million."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210980,"accession_number":"0001493152-24-026622","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-07-09T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"N2OFF receives Nasdaq bid price deficiency notice; 180-day cure period","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified N2OFF that its stock (NITO) closed below $1.00 for 30 consecutive business days, violating Listing Rule 5450(a)(1).","Compliance period runs until January 6, 2025; if bid price closes at $1.00 or more for 10 consecutive days, deficiency cured.","If not cured, N2OFF may get an additional 180-day period if it meets market value of publicly held shares and intends a reverse stock split.","Failure to regain compliance within allotted periods may result in delisting from Nasdaq Capital Market.","Continued listing not immediately affected; stock remains traded under NITO symbol."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210979,"accession_number":"0001493152-24-026187","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-07-03T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"N2OFF shareholders approve reverse stock split; authorized capital increase fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split approved by 88.61% of votes cast; ratio range 1:2 to 1:35, board controls timing.","Proposal to increase authorized shares from 500M to 10B failed with only 37.77% of voting power in favor.","Adjournment proposal approved to allow further solicitation if needed, but not used after results.","Quorum of ~57.48% (1,978,049 of 3,441,097 shares) represented at special meeting on June 28, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229460,"accession_number":"0001493152-24-014741","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-04-16T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"N2OFF issues $1.5M promissory note to YA II PN, net $1.455M after 3% OID","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Sold $1,500,000 note to YA II PN, Ltd.; proceeds $1,455,000 (3% original issue discount).","Interest 8% per annum, maturity April 4, 2025; monthly principal payments of $150,000 start June 3, 2024.","Payments may be in cash or via shares under existing Standby Equity Purchase Agreement (Dec 22, 2023).","Defaults include Nasdaq delisting and failure to file timely SEC reports; default interest rate 18%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248015,"accession_number":"0001493152-24-010423","cik":1789192,"company_name":"Nexentis Technologies Inc.","ticker":"NXTS","form_type":"8-K","filed_at":"2024-03-19T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"Save Foods rebrands as N2OFF Inc., ticker changes to NITO on March 19, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company changed name from Save Foods, Inc. to N2OFF, Inc. effective March 19, 2024 at 12:01 a.m. PT.","Nasdaq ticker symbol changed from SVFD to NITO, effective at market open on March 19, 2024.","Rebranding reflects focus on sustainable environmental solutions, including N2O emission mitigation via NTWO OFF Ltd.","Stockholders approved name change at special meeting on February 8, 2024; amendment filed March 15, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3631842.0465306123,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}